Literature DB >> 19107762

Genetic susceptibility of lung cancer associated with common variants in the 3' untranslated regions of the adenosine triphosphate-binding cassette B1 (ABCB1) and ABCC1 candidate transporter genes for carcinogen export.

Haijian Wang1, Guangfu Jin, Haifeng Wang, Gaifen Liu, Ji Qian, Li Jin, Qingyi Wei, Hongbing Shen, Wei Huang, Daru Lu.   

Abstract

BACKGROUND: Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NKK) is a well defined carcinogen that can induce lung cancer. Genetic polymorphisms in its disposition pathways could modify the risk of developing lung cancer. The authors of this report previously catalogued the sequence variations of the adenosine triphosphate-binding cassette B1 (ABCB1) and ABCC1 candidate transporter genes for carcinogen export in the Chinese population and screened out common variants with potential function in their 5' flanking and 3' untranslated regions. The objective of the current study was to test the hypothesis that these common variants are associated with lung cancer risk.
METHODS: The genotyping analyses for 6 common regulatory variants (reference single-nucleotide polymorphism 4728709 [rs4728709] and rs2188524 in the 5' flanking region of ABCB1 and rs3842 in its 3' untranslated region; rs3743527, rs212090, and rs212091 in the 3' untranslated region of ABCC1) was conducted in a case-control study of 500 patients with incident lung cancer and 517 cancer-free controls in a Chinese population.
RESULTS: Compared with the wild adenosine/adenosine (A/A) genotype, the variant rs3842 genotype (adenosine/guanosine [A/G] + G/G) of ABCB1 was associated with a statistically significant increased risk of developing lung cancer (odds ratio [OR]. 1.36; 95% confidence interval [95% CI], 1.06-1.76). Also evident was the association between cancer susceptibility and the variant rs212090 genotype (adenosine/thymidine [A/T] + T/T) of ABCC1 (OR, 1.37; 95% CI, 1.03-1.83). Haplotype-based association analysis also emphasized that 2 common haplotypes carrying the culprit alleles of the 2 single-nucleotide polymorphisms were associated with an increased risk of cancer. In addition, stratification analysis demonstrated a remarkable association of ABCB1 rs3842 with the risk of cancer manifested in women (OR, 2.57; 95% CI, 1.36-4.85), in the histologic type of adenocarcinoma (OR, 1.42; 95% CI, 1.03-1.99), and in individuals aged <60 years (OR, 1.50; 95% CI, 1.05-2.14).
CONCLUSIONS: The current study demonstrated that common polymorphisms in the 3' untranslated region of ABCB1 and ABCC1 may contribute to the etiology of lung cancer, providing further support for the hypothesis that genetic components in the metabolism and the disposition of NNK may modify the risk of lung cancer, especially in lung adenocarcinoma among women. Functional studies are warranted to elucidate whether aberrant expression and dysfunction of ABC transporters for carcinogen export may play a role in the development of lung cancer. (c) 2008 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19107762     DOI: 10.1002/cncr.24042

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

Review 1.  How cigarette smoke skews immune responses to promote infection, lung disease and cancer.

Authors:  Martin R Stämpfli; Gary P Anderson
Journal:  Nat Rev Immunol       Date:  2009-05       Impact factor: 53.106

Review 2.  Lung cancer in women.

Authors:  Raúl Barrera-Rodriguez; Jorge Morales-Fuentes
Journal:  Lung Cancer (Auckl)       Date:  2012-12-15

Review 3.  Multidrug resistance-associated protein 1 (MRP1/ABCC1) polymorphism: from discovery to clinical application.

Authors:  Jiye Yin; Jianting Zhang
Journal:  Zhong Nan Da Xue Xue Bao Yi Xue Ban       Date:  2011-10

4.  Hypermethylation of ATP-binding cassette B1 (ABCB1) multidrug resistance 1 (MDR1) is associated with cisplatin resistance in the A549 lung adenocarcinoma cell line.

Authors:  Angui Li; Jianfei Song; Qi Lai; Bangqing Liu; Haiyong Wang; Yinhui Xu; Xiaoyan Feng; Xiaolin Sun; Zhenzong Du
Journal:  Int J Exp Pathol       Date:  2016-12-20       Impact factor: 1.925

5.  High-order SNP combinations associated with complex diseases: efficient discovery, statistical power and functional interactions.

Authors:  Gang Fang; Majda Haznadar; Wen Wang; Haoyu Yu; Michael Steinbach; Timothy R Church; William S Oetting; Brian Van Ness; Vipin Kumar
Journal:  PLoS One       Date:  2012-04-19       Impact factor: 3.240

6.  Pharmacogenomic characterization of gemcitabine response--a framework for data integration to enable personalized medicine.

Authors:  Michael Harris; Krithika Bhuvaneshwar; Thanemozhi Natarajan; Laura Sheahan; Difei Wang; Mahlet G Tadesse; Ira Shoulson; Ross Filice; Kenneth Steadman; Michael J Pishvaian; Subha Madhavan; John Deeken
Journal:  Pharmacogenet Genomics       Date:  2014-02       Impact factor: 2.089

7.  Polymorphisms at microRNA binding sites of Ara-C and anthracyclines-metabolic pathway genes are associated with outcome of acute myeloid leukemia patients.

Authors:  Hai-Xia Cao; Chao-Feng Miao; Liang Yan; Ping Tang; Li-Rong Zhang; Ling Sun
Journal:  J Transl Med       Date:  2017-11-15       Impact factor: 5.531

8.  The effect of CHRNA3 rs1051730 C>T and ABCB1 rs3842 A>G polymorphisms on non-small cell lung cancer and nicotine dependence in Iranian population.

Authors:  Parisa Veiskarami; Massoud Houshmand; Sharareh Seifi; Nafiseh Ansarinejad; Farshid Fardad; Bahareh Abbasi
Journal:  Heliyon       Date:  2021-08-24

9.  Pathway-based analysis using genome-wide association data from a Korean non-small cell lung cancer study.

Authors:  Donghoon Lee; Geon Kook Lee; Kyong-Ah Yoon; Jin Soo Lee
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

10.  Molecular epidemiology of female lung cancer.

Authors:  Seon-Hee Yim; Yeun-Jun Chung
Journal:  Cancers (Basel)       Date:  2011-04-01       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.